Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19

NCT04473170 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

146

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronavirus Disease 2019 (COVID-19)

Interventions

BIOLOGICAL: Autologous Non-Hematopoietic Peripheral Blood Stem Cells (NHPBSC)
DRUG: COVID-19 standard care

Sponsor

Abu Dhabi Stem Cells Center